GB201609866D0 - Antibodies, uses thereof and conjugates thereof - Google Patents

Antibodies, uses thereof and conjugates thereof

Info

Publication number
GB201609866D0
GB201609866D0 GBGB1609866.7A GB201609866A GB201609866D0 GB 201609866 D0 GB201609866 D0 GB 201609866D0 GB 201609866 A GB201609866 A GB 201609866A GB 201609866 D0 GB201609866 D0 GB 201609866D0
Authority
GB
United Kingdom
Prior art keywords
conjugates
antibodies
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1609866.7A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abzena UK Ltd
Original Assignee
Polytherics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Polytherics Ltd filed Critical Polytherics Ltd
Priority to GBGB1609866.7A priority Critical patent/GB201609866D0/en
Publication of GB201609866D0 publication Critical patent/GB201609866D0/en
Priority to EP17730240.3A priority patent/EP3464379B1/en
Priority to EP23199243.9A priority patent/EP4282434A3/en
Priority to PCT/GB2017/051638 priority patent/WO2017212250A1/en
Priority to ES17730240T priority patent/ES2965349T3/en
Priority to US16/303,596 priority patent/US11485792B2/en
Priority to JP2019516285A priority patent/JP7179719B2/en
Priority to CN202311507569.2A priority patent/CN117534764A/en
Priority to CN201780035044.XA priority patent/CN109311996B/en
Priority to JP2022183458A priority patent/JP2023017999A/en
Ceased legal-status Critical Current

Links

GBGB1609866.7A 2016-06-06 2016-06-06 Antibodies, uses thereof and conjugates thereof Ceased GB201609866D0 (en)

Priority Applications (10)

Application Number Priority Date Filing Date Title
GBGB1609866.7A GB201609866D0 (en) 2016-06-06 2016-06-06 Antibodies, uses thereof and conjugates thereof
CN201780035044.XA CN109311996B (en) 2016-06-06 2017-06-06 Antibodies, uses thereof and conjugates thereof
ES17730240T ES2965349T3 (en) 2016-06-06 2017-06-06 Antibodies, their uses and their conjugates
EP23199243.9A EP4282434A3 (en) 2016-06-06 2017-06-06 Antibodies, uses thereof and conjugates thereof
PCT/GB2017/051638 WO2017212250A1 (en) 2016-06-06 2017-06-06 Antibodies, uses thereof and conjugates thereof
EP17730240.3A EP3464379B1 (en) 2016-06-06 2017-06-06 Antibodies, uses thereof and conjugates thereof
US16/303,596 US11485792B2 (en) 2016-06-06 2017-06-06 Antibodies, uses thereof and conjugates thereof
JP2019516285A JP7179719B2 (en) 2016-06-06 2017-06-06 Antibodies, uses thereof and conjugates thereof
CN202311507569.2A CN117534764A (en) 2016-06-06 2017-06-06 Antibodies, uses thereof and conjugates thereof
JP2022183458A JP2023017999A (en) 2016-06-06 2022-11-16 Antibodies, uses thereof and conjugates thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1609866.7A GB201609866D0 (en) 2016-06-06 2016-06-06 Antibodies, uses thereof and conjugates thereof

Publications (1)

Publication Number Publication Date
GB201609866D0 true GB201609866D0 (en) 2016-07-20

Family

ID=56508141

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1609866.7A Ceased GB201609866D0 (en) 2016-06-06 2016-06-06 Antibodies, uses thereof and conjugates thereof

Country Status (1)

Country Link
GB (1) GB201609866D0 (en)

Similar Documents

Publication Publication Date Title
IL264654B1 (en) Anti-tigit antibodies, anti-pvrig antibodies and combinations thereof
IL290457A (en) Antibodies and conjugates thereof
IL267942B (en) Anti-cd73 antibodies and uses thereof
HK1253305A1 (en) Cd123 antibodies and conjugates thereof
IL262497A (en) Anti-il-33 antibodies, compositions, methods and uses thereof
IL268734A (en) Anti-lag-3 antibodies and uses thereof
IL268700A (en) Anti-phf-tau antibodies and uses thereof
IL262095A (en) Anti-pacap antibodies and uses thereof
HK1248538A1 (en) Cd48 antibodies and conjugates thereof
ZA201901935B (en) Anti-il-33 antibodies and uses thereof
IL265471A (en) Affinity-oligonucleotide conjugates and uses thereof
IL252430A0 (en) Antibodies, uses and methods
GB201614162D0 (en) Antibodies, uses thereof and conjugates thereof
IL266049A (en) Anti-o1 antibodies and uses thereof
IL266082A (en) Anti-chikv antibodies and uses thereof
IL264417A (en) Anti-o2 antibodies and uses thereof
GB201712032D0 (en) Antibodies and uses thereof
HK1252350A1 (en) Mrka polypeptides, antibodies, and uses thereof
GB201708105D0 (en) Antibodies, uses thereof and conjugates thereof
GB201609866D0 (en) Antibodies, uses thereof and conjugates thereof
GB201618515D0 (en) Combinations comprising antibodies, uses and methods

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)